Mitotic progression following DNA damage enables pattern recognition within micronuclei
2017 · Nature · 1,408 citations
https://doi.org/10.1038/nature23470
J
Joseph L. Benci
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
46
Papers
6.7K
Citations
14
h-index
18
i10-index
Joseph L. Benci is an academic researcher from Bristol-Myers Squibb (United States). The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immune cells in cancer & Nanoplatforms for cancer theranostics. The author has an h-index of 14, co-authored 40 publications.
ORCID: 0000-0002-1759-4621Papers by this author
worksTumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
2016 · Cell · 1,110 citations
https://doi.org/10.1016/j.cell.2016.11.022
Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade
2019 · Cell · 539 citations
https://doi.org/10.1016/j.cell.2019.07.019
Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination
2017 · Molecular Cell · 275 citations
https://doi.org/10.1016/j.molcel.2017.06.008
Factors Influencing Delivery of Cancer Survivorship Care Plans: A National Patterns of Care Study
2020 · Frontiers in Oncology · 11 citations
https://doi.org/10.3389/fonc.2019.01577
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat